Men with prostate cancer are being given false hope by tests that underestimate the aggressiveness of their disease, a study suggests.
Researchers found that more than half of a group of men whose cancers were initially classified as slow-growing and confined turned out to have more dangerous tumours.
The findings, published in the British Journal Of Cancer, call into question the ability of experts to grade and stage prostate cancers on the basis of biopsy samples.
It also casts doubt on the "active surveillance" strategy of avoiding unnecessary radical treatment for patients with slow-growing prostate cancer.
Instead, these patients are often closely monitored but left alone until tests suggest their condition has worsened.
More top news
Selena Gomez said she needs to "rethink some areas of my life" as she feels "extremely unauthentic" and "unconnected" to her music.
Although it may be a dry and bright start for most, thicker cloud and rain will spread in through the day.
US Democrats must heed the warning of the UK's EU referendum vote to avoid a Donald Trump presidency, Kezia Dugdale has said.